Marketing-authorisation holder · Brazil

Sanusphar Pesquisa E Desenvovimento Ltda

Brazil10 medicines1 country

10 medicines in 1 country, as authorisation holder.

Medicines

Every medicine in the registers under its name, current ones first.

10 medicines

Medicine	Substance	Country	Status	Authorised
ARDIC	Empagliflozin	Brazil	Authorised	2026
benzoato de alogliptina + cloridrato de pioglitazona	Alogliptin, Pioglitazone	Brazil	Authorised	2025
cloreto de sódio 0,9%	Cloreto	Brazil	Authorised	2025
cloridrato de metformina + benzoato de alogliptina	Alogliptin, Metformin	Brazil	Authorised	2025
DESTYC	Desvenlafaxine	Brazil	Authorised	2021
EMBARD	Empagliflozin	Brazil	Authorised	2026
empagliflozina	Empagliflozin	Brazil	Authorised	2026
MAYCOURI	Diosmina, Hesperidina	Brazil	Authorised	2026
TIFEIVO	Ferripolimaltose	Brazil	Authorised	2026
VANNOFLEIVO	Diosmina, Hesperidina	Brazil	Authorised	2026

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Marketing-authorisation holder · Brazil

Sanusphar Pesquisa E Desenvovimento Ltda

Brazil10 medicines1 country

10 medicines in 1 country, as authorisation holder.

Its medicines

Medicines

Every medicine in the registers under its name, current ones first.

10 medicines

Medicine	Substance	Country	Status	Authorised
ARDIC	Empagliflozin	Brazil	Authorised	2026
benzoato de alogliptina + cloridrato de pioglitazona	Alogliptin, Pioglitazone	Brazil	Authorised	2025
cloreto de sódio 0,9%	Cloreto	Brazil	Authorised	2025
cloridrato de metformina + benzoato de alogliptina	Alogliptin, Metformin	Brazil	Authorised	2025
DESTYC	Desvenlafaxine	Brazil	Authorised	2021
EMBARD	Empagliflozin	Brazil	Authorised	2026
empagliflozina	Empagliflozin	Brazil	Authorised	2026
MAYCOURI	Diosmina, Hesperidina	Brazil	Authorised	2026
TIFEIVO	Ferripolimaltose	Brazil	Authorised	2026
VANNOFLEIVO	Diosmina, Hesperidina	Brazil	Authorised	2026

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Brazil	10	10	0	Companies All medicines

Therapeutic areas

The ATC groups most of its medicines belong to, largest first.

VasoprotectivesCardiovascular system · ATC C05C

Top substances

The active substances in most of its medicines.

Names in the registers

How the registers spell it, normalised: legal forms, accents and capitals removed.

sanusphar pesquisa e desenvovimento

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

ANVISA / CMED

ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date

Licence: Other (Public Domain)

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions

Report an error or request removalCorrections from the company itself are welcome.

At a glance

Type: Marketing-authorisation holder
Headquarters: Brazil
Medicines: 10
Countries: 1
Roles: Authorisation holder

Brazil: more companies

Ranked by their number of medicines.

Show all